Reference
Di Federico A, et al. Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible?. Anti-Cancer Drugs : no pagination, 19 Aug 2020. Available from: URL: http://doi.org/10.1097/CAD.0000000000000987
Rights and permissions
About this article
Cite this article
Capecitabine/oxaliplatin. Reactions Weekly 1823, 105 (2020). https://doi.org/10.1007/s40278-020-83733-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-83733-8